Clinical TrialsSearch results
Number of results: 386
Other
- Surgical outcome of trabeculectomy: phakia versus pseudophakia
- Patients with primary open-angle glaucoma, or patients with exfoliation glaucoma.
- Kumamoto University
- 2008-06-18
Other
- Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomy
- Patients with open-angle glaucoma after trabeculectomy
- Kumamoto University
- 2007-11-15
Other
- Importance of checking exon skipping events prior to clinical trials using systemically delivered antisense morpholino in Duchenne muscular dystrophy patients
- Duchenne muscular dystrophy
- Kumamoto University
- 2009-06-01
Other
- Prognostic value of CD144 positive endothelium-derived-microparticles (CD144-EMP) in patients with heart failure
- Japanese patinets with heart failure
- Kumamoto University Hospital
- 2009-07-30
Other
- Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer
- non small cell lung cancer
- Kumamoto University School of Medicine
- 2005-09-04
Other
- Optimal combination of pharmacological agents for cardiovascular and renal complications of diabetes mellitus and impaired glucose tolerance
- Cardiovascular and renal complications of diabetes mellitus and impaired glucose tolerance
- Kyoto Medical Centar
- 2009-04-01
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- Phase II study of sequential administration of FEC (Fluorouracil / Epirubicin / Cyclophosphamide) followed by Docetaxel as adjuvant chemotherapy for node-positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-04-06
Other
- Neo-adjuvant therapy with paclitaxel followed by FEC fluoraouracil, epirubicin and cyclophosphamide) for primary breast cancer(KBC-SG0801)
- Primary breast cancer
- Kyushu Breast Cancer Study Group
- 2009-02-27
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17